Tenaya Therapeutics, Inc.
TNYA
$0.72
$0.011.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.26% | 15.36% | 20.91% | 20.89% | 16.64% |
| Total Depreciation and Amortization | -33.75% | -12.54% | -11.28% | -1.84% | 23.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.85% | -20.02% | -25.55% | -18.67% | -10.41% |
| Change in Net Operating Assets | -33.42% | 186.20% | 30.07% | 151.93% | 5.61% |
| Cash from Operations | 16.78% | 24.19% | 21.36% | 33.89% | 19.36% |
| Capital Expenditure | 97.13% | 67.16% | 85.87% | -94.52% | 32.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 129.71% | 15.87% | 677.96% |
| Cash from Investing | -100.05% | -100.48% | 129.44% | 15.60% | 596.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 15,348.81% | 1,125.81% | -- | 7.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.83% | 15,348.81% | 1,125.81% | -183.51% | 7.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -139.76% | 1,231.91% | 87.26% | 721.44% | 263.01% |